Rachel Thompson
Senior Associate, Investment Banking
Since 2019, Rachel Thompson has been an integral part of Back Bay’s investment banking team, supporting biopharma, medtech and healthtech clients through strategic deal execution across a range of therapeutic areas, including multiple neuro/CNS focused-transactions.
Ms. Thompson’s expertise includes primary and secondary research, strategic positioning and marketing materials, valuation analyses, and in-depth industry analysis. Her expertise and approach with clients led Consulting Magazine to name Ms. Thompson among the 2022 Rising Stars of the Profession, Ones to Watch for Excellence in Financial Consulting.
Ms. Thompson holds a Bachelor of Science in Biology with a concentration in Bioinformatics from Boston College.
Highlights from recent industry articles by Ms. Thompson:
SPACS: A Popular Alternative to Biotech IPOs
Life Science SPACs: Here to Stay
With Biotech Public Valuations Down, Look to Alternative Strategies to Enhance Company Value